Why Precision Optics Corporation, Inc.’s (POCI) Stock Is Up 5.47%
As of Monday, July 13, Precision Optics Corporation, Inc.’s POCI share price has surged by 5.47%, which has investors questioning if this is right time to sell.Michael Rose
Stock Evaluator: Precision Optics Corporation, Inc. (POCI)
Precision Optics Corporation, Inc. POCI
$4.78
0.02
0.42%
September 24, 2026 4:00:00 PM
EST
Volume: 62,898
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Commentary & Analysis
Why Precision Optics Corporation, Inc.’s (POCI) Stock Is Up 6.09%
As of Friday, June 26, Precision Optics Corporation, Inc.’s POCI share price has surged by 6.09%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Precision Optics Corporation, Inc.’s (POCI) Stock Is Up 5.53%
As of Thursday, June 18, Precision Optics Corporation, Inc.’s POCI share price has surged by 5.53%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Precision Optics Corporation, Inc.’s (POCI) Stock Is Up 12.16%
As of Monday, May 18, Precision Optics Corporation, Inc.’s POCI share price has surged by 12.16%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Precision Optics Corporation, Inc.’s (POCI) Stock Is Up 6.09%
As of Thursday, May 14, Precision Optics Corporation, Inc.’s POCI share price has surged by 6.09%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | POCI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $51.7 | $367.8 | 15% |
|
| Shares Out (Mil) | 7.8 | 40.8 | 18% |
|
| Institutional Ownership | 65.3% | 82.8% | 41% |
|
| Float (Mil) | 8.3 | 35.5 | 17% |
|
| Beta | 0.31 | 0.85 | 19% |
|
| Avg Daily Volume (000s) | 43 | 310 | 27% |
|
| Price Change (52-week) |
7.3% | 65.6% | 58% |
|
| Growth | POCI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 14.0% | 11.8% | 71% |
|
| Net Income (5yr) | (32.9%) | (5.7%) | 12% |
|
| EPS (5yr) | (20.9%) | 10.2% | 12 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 22.3% | (15.5%) | 81% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | POCI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $29 | $119 | 15% |
|
| Net Income (TTM) (Mil) | ($5) | ($9) | 33% |
|
| EPS (TTM) | ($0.638) | ($0.400) | 25% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | ($3) | 30% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $1 | 55% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $23 | 22% |
|
| Enterprise Value (Q1) (Mil) | $56 | $376 | 17% |
|
| Valuation | POCI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.57 | 2.72 | 61% |
|
| P/E | na | 25.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | POCI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 13.8% | 58.5% | 13% |
|
| Net Margin | (17.0%) | (6.9%) | 17% |
|
| ROA | (18.5%) | (12.3%) | 21% |
|
| ROE | (29.6%) | (11.1%) | 20% |
|
| Liabilities to Assets | 40.3% | 46.6% | 31% |
|
| F-Score | 4 | 4 | 33% |
|
Passing Stock Screens
As of 9/23/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Price-to-Sales Screen
Factors: Value, Growth
Research indicates that using price-to-sales ratios may lead to better investment results than price-to-book-value ratios or price-earnings ratios.
| Performance Since Inception: | 13.2% |
| +/- S&P 500: | +5.7 |
